Patent · US Active

Process for preparing ixazomib citrate and intermediates therefor

US10118937B1 · kind B1 · utility

0Cited by
1References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 3, 2018
Grant dateNov 6, 2018
Priority date—
Expiry dateJan 3, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F5/025
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A process for making ixazomib citrate of formula VI comprising reacting a compound of formula V with citric acid to form ixazomib citrate of formula VI:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.